Top Stories
Top Stories
Wires

Insys Therapeutics files for Chapter 11 bankruptcy

June 10 (Reuters) - Drugmaker Insys Therapeutics Inc said on Monday it filed for Chapter 11 bankruptcy protection, a week after agreeing to pay $225 million to settle a U.S. probe into bribes the company paid to doctors for prescribing a powerful opioid medication. (Reporting by Manas Mishra in Bengaluru; Editing by Anil D'Silva)